254 related articles for article (PubMed ID: 29017084)
41. Adenovirus-associated hemorrhagic cystitis in a pediatric renal transplant recipient.
Keswani M; Moudgil A
Pediatr Transplant; 2007 Aug; 11(5):568-71. PubMed ID: 17631031
[TBL] [Abstract][Full Text] [Related]
42. Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation.
Papanicolaou GA; Lee YJ; Young JW; Seshan SV; Boruchov AM; Chittick G; Momméja-Marin H; Glezerman IG
Am J Kidney Dis; 2015 May; 65(5):780-4. PubMed ID: 25600489
[TBL] [Abstract][Full Text] [Related]
43. Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.
Philippe M; Ranchon F; Gilis L; Schwiertz V; Vantard N; Ader F; Labussiere-Wallet H; Thomas X; Nicolini FE; Wattel E; Ducastelle-Leprêtre S; Barraco F; Lebras L; Salles G; Michallet M; Rioufol C
Biol Blood Marrow Transplant; 2016 Apr; 22(4):723-730. PubMed ID: 26718666
[TBL] [Abstract][Full Text] [Related]
44. Oral brincidofovir decreases the incidence of HHV-6B viremia after allogeneic HCT.
Hill JA; Nichols WG; Marty FM; Papanicolaou GA; Brundage TM; Lanier R; Zerr DM; Boeckh MJ
Blood; 2020 Apr; 135(17):1447-1451. PubMed ID: 32076716
[TBL] [Abstract][Full Text] [Related]
45. Adenovirus infection after allogeneic stem cell transplantation.
Feuchtinger T; Lang P; Handgretinger R
Leuk Lymphoma; 2007 Feb; 48(2):244-55. PubMed ID: 17325884
[TBL] [Abstract][Full Text] [Related]
46. The effect of cidofovir on adenovirus plasma DNA levels in stem cell transplantation recipients without T cell reconstitution.
Lugthart G; Oomen MA; Jol-van der Zijde CM; Ball LM; Bresters D; Kollen WJ; Smiers FJ; Vermont CL; Bredius RG; Schilham MW; van Tol MJ; Lankester AC
Biol Blood Marrow Transplant; 2015 Feb; 21(2):293-9. PubMed ID: 25464118
[TBL] [Abstract][Full Text] [Related]
47. Occurrence, risk factors and outcome of adenovirus infection in adult recipients of allogeneic hematopoietic stem cell transplantation.
Hubmann M; Fritsch S; Zoellner AK; Prevalsek D; Engel N; Bücklein V; Mumm F; Schulz C; Stemmler HJ; Jäger G; Ledderose G; Kolb HJ; Hausmann A; Hiddemann W; Moosmann A; Tischer J
J Clin Virol; 2016 Sep; 82():33-40. PubMed ID: 27428881
[TBL] [Abstract][Full Text] [Related]
48. Treatment of adenovirus infections in patients undergoing allogeneic hematopoietic stem cell transplantation.
Bordigoni P; Carret AS; Venard V; Witz F; Le Faou A
Clin Infect Dis; 2001 May; 32(9):1290-7. PubMed ID: 11303263
[TBL] [Abstract][Full Text] [Related]
49. Treatment of adenovirus pneumonia with cidofovir in pediatric lung transplant recipients.
Doan ML; Mallory GB; Kaplan SL; Dishop MK; Schecter MG; McKenzie ED; Heinle JS; Elidemir O
J Heart Lung Transplant; 2007 Sep; 26(9):883-9. PubMed ID: 17845926
[TBL] [Abstract][Full Text] [Related]
50. Adenovirus Viremia in Adult CD34(+) Selected Hematopoietic Cell Transplant Recipients: Low Incidence and High Clinical Impact.
Lee YJ; Huang YT; Kim SJ; Maloy M; Tamari R; Giralt SA; Papadopoulos EB; Jakubowski AA; Papanicolaou GA
Biol Blood Marrow Transplant; 2016 Jan; 22(1):174-8. PubMed ID: 26318614
[TBL] [Abstract][Full Text] [Related]
51. Brincidofovir: understanding its unique profile and potential role against adenovirus and other viral infections.
Alvarez-Cardona JJ; Whited LK; Chemaly RF
Future Microbiol; 2020 Apr; 15():389-400. PubMed ID: 32166967
[TBL] [Abstract][Full Text] [Related]
52. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning.
Kalpoe JS; van der Heiden PL; Barge RM; Houtzager S; Lankester AC; van Tol MJ; Kroes AC
Eur J Haematol; 2007 Apr; 78(4):314-21. PubMed ID: 17331130
[TBL] [Abstract][Full Text] [Related]
53. Biopsy-proven adenoviral diarrhea responding to low-dose cidofovir.
Nicolasora NP; Reddy P; Kaul DR
Transpl Infect Dis; 2008 Oct; 10(5):346-50. PubMed ID: 18282236
[TBL] [Abstract][Full Text] [Related]
54. Pharmacokinetics and safety of intravenous cidofovir for life-threatening viral infections in pediatric hematopoietic stem cell transplant recipients.
Caruso Brown AE; Cohen MN; Tong S; Braverman RS; Rooney JF; Giller R; Levin MJ
Antimicrob Agents Chemother; 2015 Jul; 59(7):3718-25. PubMed ID: 25733509
[TBL] [Abstract][Full Text] [Related]
55. Treatment of BK virus-associated hemorrhagic cystitis in pediatric hematopoietic stem cell transplant recipients with cidofovir: a single-center experience.
Kwon HJ; Kang JH; Lee JW; Chung NG; Kim HK; Cho B
Transpl Infect Dis; 2013 Dec; 15(6):569-74. PubMed ID: 24028353
[TBL] [Abstract][Full Text] [Related]
56. Successful cidofovir treatment of adenovirus-associated hemorrhagic cystitis and renal dysfunction after allogenic bone marrow transplant.
Hatakeyama N; Suzuki N; Kudoh T; Hori T; Mizue N; Tsutsumi H
Pediatr Infect Dis J; 2003 Oct; 22(10):928-9. PubMed ID: 14579818
[TBL] [Abstract][Full Text] [Related]
57. Treatment of adenovirus infections in the immunocompromised host.
Ljungman P
Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):583-8. PubMed ID: 15248091
[TBL] [Abstract][Full Text] [Related]
58. PD-1 blockade immunotherapy as a successful rescue treatment for disseminated adenovirus infection after allogeneic hematopoietic stem cell transplantation.
Zhou F; Du F; Wang Z; Xue M; Wu D; Chen S; He X
J Hematol Oncol; 2024 May; 17(1):34. PubMed ID: 38764055
[TBL] [Abstract][Full Text] [Related]
59. Neonatal adenoviral infection: a seventeen year experience and review of the literature.
Ronchi A; Doern C; Brock E; Pugni L; Sánchez PJ
J Pediatr; 2014 Mar; 164(3):529-35.e1-4. PubMed ID: 24359940
[TBL] [Abstract][Full Text] [Related]
60. Renal Toxicity in Pediatric Patients Receiving Cidofovir for the Treatment of Adenovirus Infection.
Vora SB; Brothers AW; Englund JA
J Pediatric Infect Dis Soc; 2017 Nov; 6(4):399-402. PubMed ID: 28419263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
